Services

Toxicology

Pharmacology

Animal Model Development

Medical Device Testing

In Vitro Screening

Custom Assay Development

Vivarium Rental

Histology

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Species

Non-human Primates

Dogs

Mini-Pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Careers

Request a Quote

☰

Pfizer Quietly Takes 16.4% Stake in This SoCal Medtech Firm

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x425-pfizer.jpg" NAME"Pfizer Quietly Takes 16.4% Stake in This SoCal Medtech Firm" ALT"Pfizer Quietly Takes 16.4% Stake in This SoCal Medtech Firm"February 14, 2017By Mark Terry, BioSpace.com Breaking News StaffWith...…

Continue ReadingPfizer Quietly Takes 16.4% Stake in This SoCal Medtech Firm

Former Celgene and Medtronic CEOs Just Acquired This Maryland Biotech

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-deal2.jpg" NAME"Former Celgene and Medtronic CEOs Just Acquired This Maryland Biotech" ALT"Former Celgene and Medtronic CEOs Just Acquired This Maryland Biotech"February 14, 2017By Alex Keown, BioSpace.com Breaking News Staff...…

Continue ReadingFormer Celgene and Medtronic CEOs Just Acquired This Maryland Biotech

Roche Faces Off With Itself for $9 Billion Breast Cancer Drug Business

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-roche.jpg" NAME"Roche Faces Off With Itself for $9 Billion Breast Cancer Drug Business" ALT"Roche Faces Off With Itself for $9 Billion Breast Cancer Drug Business"February 14, 2017By Alex Keown,…

Continue ReadingRoche Faces Off With Itself for $9 Billion Breast Cancer Drug Business

Sponsors Request More Bioequivalence Details in EMA Guideline on Multi-Region Clinical Trials

Sponsors would like to see clearer recommendations for non-inferiority assessments, demonstrating bioequivalence and targets for statistical analysis, before the European Medicines Agency adopts an international guideline on large clinical trials…

Continue ReadingSponsors Request More Bioequivalence Details in EMA Guideline on Multi-Region Clinical Trials